Quarterly ResultMay 6, 2026, 04:26 PM
electroCore Q1 Net Sales $9.58M; Net Loss Widens to $5.27M; Going Concern Doubt
AI Summary
electroCore, Inc. reported a 42.6% increase in net sales to $9.58 million for Q1 2026, with gross profit rising 46.6% to $8.36 million. However, the company's net loss widened to $5.27 million from $3.86 million in the prior year, and diluted net loss per share increased to $(0.59). The company also disclosed substantial doubt about its ability to continue as a going concern due to forecasted cash being less than operating requirements.
Key Highlights
- Net sales increased 42.6% to $9.58 million for Q1 2026.
- Gross profit rose 46.6% to $8.36 million.
- Net loss widened to $5.27 million from $3.86 million in Q1 2025.
- Diluted net loss per share was $(0.59), compared to $(0.47) in Q1 2025.
- Cash and cash equivalents decreased to $4.85 million as of March 31, 2026.
- Company raises substantial doubt about its ability to continue as a going concern.
- US Rx sales reached $7.42 million, and General Wellness sales were $1.59 million.
- The VA channel accounted for 74.8% of total net sales.